EXHIBIT 7(1)Agreement With Respect to Schedule 13d • October 14th, 2003 • Blackfriars Corp • Wholesale-hardware & plumbing & heating equipment & supplies
Contract Type FiledOctober 14th, 2003 Company IndustryThe undersigned hereby agree that any Statement on Schedule 13D to be filed with the Securities and Exchange Commission by any of the undersigned, including any amendment thereto, with respect to securities of Noland Company, a Virginia corporation, may be filed by Blackfriars Corp., on behalf of all of the undersigned.
AGREEMENT WITH RESPECT TO SCHEDULE 13DAgreement With Respect to Schedule 13d • June 19th, 2007 • Bay City Capital LLC • Biological products, (no disgnostic substances)
Contract Type FiledJune 19th, 2007 Company IndustryEach of Bay City Capital LLC, Bay City Capital Management IV LLC, Bay City Capital Fund IV, L.P. and Bay City Capital Fund IV Co-Investment Fund, L.P. hereby express its agreement that the attached Schedule 13D (and any amendments thereto) relating to the common stock of VIA Pharmaceuticals, Inc. is filed on behalf of each of them.
AGREEMENT WITH RESPECT TO SCHEDULE 13DAgreement With Respect to Schedule 13d • May 8th, 2006 • Bay City Capital LLC • In vitro & in vivo diagnostic substances
Contract Type FiledMay 8th, 2006 Company IndustryEach of Bay City Capital LLC, Bay City Capital Management IV LLC, Bay City Capital Fund IV, L.P. and Bay City Capital Fund IV Co-Investment Fund, L.P. hereby express its agreement that the attached Schedule 13D (and any amendments thereto) relating to the common stock of NeoRx Corporation is filed on behalf of each of them.
AGREEMENT WITH RESPECT TO SCHEDULE 13DAgreement With Respect to Schedule 13d • November 21st, 2007 • Bay City Capital LLC • Electromedical & electrotherapeutic apparatus
Contract Type FiledNovember 21st, 2007 Company IndustryEach of Bay City Capital LLC, Bay City Capital Management IV LLC, Bay City Capital Fund IV, L.P. and Bay City Capital Fund IV Co-Investment Fund, L.P. hereby express its agreement that the attached Schedule 13D (and any amendments thereto) relating to the common stock of EnteroMedics Inc. is filed on behalf of each of them.